The ongoing 2026 Ebola epidemic, centered in the Democratic Republic of the Congo's Ituri Province and driven by the Bundibugyo strain, has rapidly escalated into a public health emergency of international concern since its May confirmation, with thousands of confirmed cases and high fatality rates fueling trader focus on likely affected nations. Spillover reached Uganda early, producing about 20 cases before authorities declared the outbreak over in late July following the last patient's discharge. No approved vaccine or treatment exists for this variant, and conflict plus population movement in the region complicate containment, raising the odds of further cross-border transmission via travel. With the outbreak still active into August and international screening underway, markets price in sustained risk primarily for Central and East African countries while assigning lower probabilities to distant nations absent new exported cases.